Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents.
Derzko
Natalie M
NM
Fitzpatrick, Cella, Harper & Scinto, 1900 K Street, NW, Washington, DC 20006-1110, USA. nderzko@fchs.com
Behringer
John W
JW
D001709:Biotechnology / Q000331:legislation & jurisprudence*; D003132:Commerce / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D019983:Guideline Adherence / Q000331:legislation & jurisprudence; D010067:Ownership / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States